Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$200,304
+$54,061 QoQ
Shares Held
167
+5.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#4,433
of 4,605 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Boreal Capital Management LLC holds $962,390 across 10 Drug Manufacturers - General names. LLY ranks #2 (20.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,001 | $251,891 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
167 | $200,304 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
3,385 | $195,043 | |
| 4 | NVO |
Novo Nordisk A S
|
2,751 | $131,882 | |
| 5 | JNJ |
Johnson & Johnson
|
280 | $71,111 | |
| 6 | MRK |
Merck & Co., Inc.
|
390 | $50,115 | |
| 7 | PFE |
Pfizer Inc
|
1,664 | $40,069 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
93 | $11,749 |
All Filings in LLY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $200,304 | 167 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $146,243 | 159 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $170,874 | 159 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $121,317 | 159 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $123,945 | 159 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||